Prakash Bhuyan named SpyBiotech CMO

SpyBiotech, a UK biotech with a novel vaccine platform technology that can target infectious diseases, cancer and chronic diseases, has appointed Prakash Bhuyan as chief medical officer (CMO).

Dr Bhuyan is an infectious disease specialist with more than 20 years of experience in academia and industry. Most recently, he was CMO at Aerium Therapeutics, a biotech focused on the discovery and development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats, which recently ceased operations. 

Before Aerium, he served as the head of clinical development for vaccines and immune therapies at AstraZeneca (LSE: AZN), organizing and managing the teams that developed the COVID solutions Vaxzevria and Evusheld (tixagevimab/cilgavimab), as well as RSV and influenza-focused products.